Michał Szabelski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michał Szabelski has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aneta Nitsch-Osuch
Department of Social Medicine and Public Health, Medical University of Warsaw, Pawińskiego 3a, 02-106 Warsaw, Poland
1 shared publication - Jakub Magdziarz Ibrahim-El-Nur
Department of Social Medicine and Public Health, Medical University of Warsaw, Pawińskiego 3a, 02-106 Warsaw, Poland
1 shared publication - Jan Łuczak
Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
1 shared publication - Joanna Rymuza
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Julia Wiktorowska
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland
1 shared publication - Katarzyna Bochniak
Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (11) , 1501
Examples of Systemic Solutions for Skill-Mix Issues—An Analysis of International Experiences with a Focus on Rural Areas
Background/Objectives: Health systems in many countries are increasingly turning to task shifting, task sharing and broader skill-mix solutions to address staff shortages and unequal access to care, particularly in rural regions. This article summarizes how different healthcare systems introduce intersecting competencies through new professional roles, the expansion of the scope of existing professions, and the transfer of selected tasks between them. The aim was also to indicate which strategies may be relevant for the Polish context. Methods: A literature review was carried out using PubMed and Embase (14 February–9 March 2025). Publications from 2010 to 2024 in English or Polish were included. The study was designed as a narrative review supported by a structured literature search. Publications and policy documents relevant to skill-mix strategies were identified through a concept-driven process and incorporated into a thematic synthesis. Results: Countries that introduced new professional roles reported better access to care and more continuity for patients. Expanding the scope of nurses, physiotherapists and pharmacists often helped reduce the workload of doctors and, in some places, also supported better treatment results or smoother work in facilities. At the same time, there were clear challenges: unclear role boundaries, gaps in training, extra workload and limited organizational support. These issues were particularly visible in rural areas, where staff shortages are the most severe. Conclusions: Skill-mix strategies can support healthcare systems by improving access and the overall quality of care. However, their success depends on clear regulations, adequate preparation and acceptance among health workers. Although many solutions are promising, further research is needed to better assess their long-term effects and usefulness in medical deserts.
- 28 May 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (11) , 1501
Open AccessExamples of Systemic Solutions for Skill-Mix Issues—An Analysis of International Experiences with a Focus on Rural Areas
Background/Objectives: Health systems in many countries are increasingly turning to task shifting, task sharing and broader skill-mix solutions to address staff shortages and unequal access to care, particularly in rural regions. This article summarizes how different healthcare systems introduce intersecting competencies through new professional roles, the expansion of the scope of existing professions, and the transfer of selected tasks between them. The aim was also to indicate which strategies may be relevant for the Polish context. Methods: A literature review was carried out using PubMed and Embase (14 February–9 March 2025). Publications from 2010 to 2024 in English or Polish were included. The study was designed as a narrative review supported by a structured literature search. Publications and policy documents relevant to skill-mix strategies were identified through a concept-driven process and incorporated into a thematic synthesis. Results: Countries that introduced new professional roles reported better access to care and more continuity for patients. Expanding the scope of nurses, physiotherapists and pharmacists often helped reduce the workload of doctors and, in some places, also supported better treatment results or smoother work in facilities. At the same time, there were clear challenges: unclear role boundaries, gaps in training, extra workload and limited organizational support. These issues were particularly visible in rural areas, where staff shortages are the most severe. Conclusions: Skill-mix strategies can support healthcare systems by improving access and the overall quality of care. However, their success depends on clear regulations, adequate preparation and acceptance among health workers. Although many solutions are promising, further research is needed to better assess their long-term effects and usefulness in medical deserts.
- Open Access
- 13 January 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 21 (4) , 208-214
Predictive value of thyroid-related biomarkers in Graves’ disease – a systematic review
Graves’ disease is the most common cause of hyperthyroidism and is characterized by a clinical course often difficult to predict. While some patients experience relapses, others achieve long-term remission. It is crucial to improve the accuracy of predicting disease course in order to identify patients who are most likely to benefit from antithyroid drug therapy, thereby avoiding potential complications associated with more radical treatments. The aim of this systematic review is to gather up-to-date knowledge in this field and, based on it, to determine whether commonly available thyroid-related biomarkers can predict the likelihood of remission after antithyroid drug therapy. Thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4) and TSH-receptor antibodies (TRAb) were evaluated. A total of 964 articles (394 from PubMed and 570 from Embase) were initially identified. After screening and eligibility assessment, 19 studies were included in the final analysis. The results of these studies were heterogenous and partly inconclusive. However, TRAb appears to be the most useful marker in predicting remission. Low baseline TRAb concentrations are associated with a higher probability of remission, while higher values correlate with a more severe clinical course and a greater risk of relapse. The predictive value of FT3 and FT4 as markers is questionable. TSH tends to be the least informative predictor of the outcome. In conclusion, looking at the nature of Graves’ disease, which may be relapsing-remitting, further research in this area is warranted to enhance the quality of life of patients with Graves’ disease.
- 13 January 2026
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 21 (4) , 208-214
Open AccessPredictive value of thyroid-related biomarkers in Graves’ disease – a systematic review
Graves’ disease is the most common cause of hyperthyroidism and is characterized by a clinical course often difficult to predict. While some patients experience relapses, others achieve long-term remission. It is crucial to improve the accuracy of predicting disease course in order to identify patients who are most likely to benefit from antithyroid drug therapy, thereby avoiding potential complications associated with more radical treatments. The aim of this systematic review is to gather up-to-date knowledge in this field and, based on it, to determine whether commonly available thyroid-related biomarkers can predict the likelihood of remission after antithyroid drug therapy. Thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4) and TSH-receptor antibodies (TRAb) were evaluated. A total of 964 articles (394 from PubMed and 570 from Embase) were initially identified. After screening and eligibility assessment, 19 studies were included in the final analysis. The results of these studies were heterogenous and partly inconclusive. However, TRAb appears to be the most useful marker in predicting remission. Low baseline TRAb concentrations are associated with a higher probability of remission, while higher values correlate with a more severe clinical course and a greater risk of relapse. The predictive value of FT3 and FT4 as markers is questionable. TSH tends to be the least informative predictor of the outcome. In conclusion, looking at the nature of Graves’ disease, which may be relapsing-remitting, further research in this area is warranted to enhance the quality of life of patients with Graves’ disease.